You are here

Home

Medical Testing

EU regulators find possible links between J&J shots and blot clots; still support the overall benefits

Tue, 2021-04-20 10:59 — mike kraft
EU regulator finds link between J&J shot and blood clots LONDON (AP) — Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the United States, but they confirmed the vaccine's benefits still outweighed the very small risks of recipients developing the unusual clots. The European Medicines Agency said a warning about the rare blood clots should be added to labels for Johnson & Johnson’s COVID-19 vaccine.
Country / Region Tags: 
Europe
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

No new blood clotting cases reported to CDC over Johnson & Johnson vaccine

Tue, 2021-04-20 10:19 — mike kraft
No new blood clotting cases over Johnson & Johnson vaccine, CDC says No new blood clotting cases have been confirmed after initial reports of such cases led federal regulators to recommend that states temporarily stop administering the Johnson & Johnson coronavirus vaccine. YahooNews
 
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Study indicates that having COVID does not mean future immunity

Fri, 2021-04-16 20:58 — mike kraft
Having COVID doesn’t guarantee immunity, study of Marine recruits finds Ten percent of Marine recruits who had COVID antibodies got COVID again during basic training. Karen Jowers Marine Corps Times
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Vaccinations
Demographics
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

Biden administration designating $1.7B for tracking, combating COVID-19 variants

Fri, 2021-04-16 10:49 — mike kraft
Biden administration investing $1.7B into tracking, combating President Biden’s administration on Friday announced its plans to invest $1.7 billion into tracking and combating COVID-19 variants as new strains make up about half of all infections across the Justine Coleman TheHill
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Medical Testing
Mutations
Public Health
Vaccinations
Contagion
Disease
Government
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Regular exercise appears to reduce severe, long-term COVID risks, study says

Wed, 2021-04-14 19:23 — mike kraft
Regular exercise appears to reduce severe, long-term COVID risks, study says Those who keep active and work a basic amount of exercise into their day-to-day face fewer COVID risks and symptoms than those who are generally more sedentary, according to a new study examining coronavirus hospitalizations and patients’ activity levels. Jessica Schladebeck nydailynews.com
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Contagion
Disease
Health
Pandemics
Problem, Solution, SitRep, or ?: 
Analysis

Discussion of 'Breakthrough' COVID Cases Among People Already Vaccinated

Tue, 2021-04-13 20:27 — mike kraft

Ginger Eatman thought she was safe after getting her second COVID-19 vaccination in February. But she kept wearing her mask, using hand sanitizer and wiping down the carts at the grocery store anyway. A few weeks later, she noticed a scratchy throat.

"By Wednesday morning, St. Patrick's Day, I was sick. I had congestion — a lot of congestion — and some coughing," says Eatman, 73, of Dallas, Ga.

Her doctor thought her symptoms might be allergies. But Eatman started feeling sicker. And then she suddenly lost her sense of smell. ...

So Eatman got tested for the coronavirus. It came back positive. ...

Eatman isn't alone in this experience. It's a long-recognized phenomenon called "vaccine breakthrough."

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Regeneron says antibody cocktail reduced Covid infections by 81% when given asi njection, not an IV

Mon, 2021-04-12 11:31 — mike kraft
Regeneron says its antibody cocktail injection prevents Covid In previous studies, antibodies had to be given intravenously. This one can be given with an under-the-skin injection. Matthew Herper STAT

Regeneron Pharmaceuticals said Monday that a single administration of its monoclonal antibody cocktail reduced the risk that volunteers exposed to Covid-19 would develop the disease by 81%.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Medical Testing
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

How concerning are links of blood clots to AstraZeneca's vaccine?

Fri, 2021-04-09 19:43 — mike kraft
How worried should we be about links of blood clots to AstraZeneca's vaccine? Europe's drug regulator on Wednesday said it had found a possible link between AstraZeneca's COVID-19 vaccine and very rare blood clots in adults who received the shot. Britain recommended people under 30 get an alternative COVID-19 vaccine if possible. John Miller, Ludwig Burger U.S.
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Data
Medical Testing
Vaccinations
Contagion
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says

Fri, 2021-04-09 19:11 — mike kraft
FDA "highly likely" to allow Pfizer's Covid-19 vaccine for children ages 12 to 15, official says It’s “highly likely” the US Food and Drug Administration will allow Pfizer’s Covid-19 vaccine to be used in children aged 12 to15, according to the acting chairman of an FDA vaccine advisory committee. By <a href="/profiles/julia-hollingsworth">Julia Hollingsworth</a>, Melissa Macaya, <a href="/profiles/melissa-mahtani">Melissa Mahtani</a>, <a href="/profiles/veronica-rocha">Veronica Rocha</a> and <a href="/profiles/fernando-alfonso-iii">Fernando Alfonso III</a>, CNN
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Contagion
Demographics
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

NIH launches study to gauge risk of allergic reactions to Pfizer, Moderna vaccines

Wed, 2021-04-07 17:55 — mike kraft
New NIH study to gauge risk of allergic reactions to Pfizer, Moderna The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals. Justine Coleman TheHill

The National Institutes of Health (NIH) announced Wednesday that it's launching a study to gauge the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Medical Testing
Vaccinations
Government
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 0.678 seconds.